KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pfizer (PFE) Tax Rate (2016 - 2026)

Pfizer has reported Tax Rate over the past 18 years, most recently at 14.54% for Q1 2026.

  • Quarterly Tax Rate rose 2133.0% to 14.54% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 4.86% through Mar 2026, up 297.0% year-over-year, with the annual reading at 3.54% for FY2025, 319.0% down from the prior year.
  • Tax Rate was 14.54% for Q1 2026 at Pfizer, up from 0.12% in the prior quarter.
  • Over five years, Tax Rate peaked at 130.1% in Q2 2024 and troughed at 6.79% in Q1 2025.
  • The 5-year median for Tax Rate is 8.56% (2024), against an average of 15.75%.
  • Year-over-year, Tax Rate skyrocketed 13323bps in 2024 and then plummeted -12547bps in 2025.
  • A 5-year view of Tax Rate shows it stood at 3.96% in 2022, then soared by 378bps to 18.89% in 2023, then plummeted by -74bps to 4.96% in 2024, then crashed by -98bps to 0.12% in 2025, then skyrocketed by 11839bps to 14.54% in 2026.
  • Per Business Quant, the three most recent readings for PFE's Tax Rate are 14.54% (Q1 2026), 0.12% (Q4 2025), and 6.48% (Q3 2025).